GAITHERSBURG, Md., Feb. 06, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by ...
LTIM, BSE: 540005], a global technology consulting and digital solutions company, today announced a contract extension with Nexi Group, a leading European PayTech provider.
Results that may be inaccessible to you are currently showing.